News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aduro Biotech Announces Two Presentations at Keystone Meeting


12/12/2012 9:22:48 AM

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. is pleased to announce that Thomas W. Dubensky, Chief Scientific Officer, and Peter Lauer, Director of Molecular Biology, have been selected to deliver oral presentations at the Immunological Mechanisms of Vaccination meeting, which is taking place from December 13-18 in Ottawa, Canada. Dr. Dubensky is scheduled to present on Friday, December 14. His presentation is entitled, “Development of Cyclic Dinucleotides (CDNs) as STING-Targeted Molecular Adjuvants.” Dr. Lauer is scheduled to present on Sunday, December 16. His presentation is entitled, “Recombinase-Induced Intracellular Death (Lm-RIID): A Novel, Safe, and Potent L. Monocytogenes Vaccine Platform.”

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES